Larin 24 Fe Kit
Product Images NDC 16714-416

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Larin 24 Fe (NDC 16714-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

A text panel titled 'Instructions for Administration of LARIN 24 Fe' providing detailed guidance on how to start using the contraceptive pill, including instructions for Day 1 Start and Sunday Start methods, tablet color coding (pale yellow active for days 1-24 and brown inactive for days 25-28), and switching instructions from other contraceptive methods such as transdermal patch, vaginal ring, injection, intrauterine contraceptive, and implant. It also highlights the need for additional non-hormonal contraception during initial use in some cases.*

FDA Label Image

2 (Image 02)

A text table titled 'Instructions for Missed LARIN 24 Fe Tablets' detailing guidelines for missed doses during different weeks of the medication cycle. It includes specific instructions on when to take missed tablets, when to start a new pack, and emphasizes the use of additional non-hormonal contraception as backup if sexual activity occurs within 7 days after missing tablets.*

FDA Label Image

3 (Image 03)

Chemical structure of the active ingredient as depicted in the image, showing a steroidal framework consistent with norethindrone acetate or ethinyl estradiol components in Larin 24 Fe.*

FDA Label Image

4 (Image 04)

Chemical structure of Norethindrone acetate, the active ingredient in Larin 24 Fe KIT by Northstar Rx LLC. The diagram depicts steroidal molecular rings with acetate and alkyne functional groups clearly illustrated.*

FDA Label Image

5 (Image 05)

A line graph showing mean plasma norethindrone concentration over time in pg/mL after single and multiple oral doses of norethindrone acetate and ethinyl estradiol tablets in healthy female volunteers. The x-axis represents time in hours up to 60 hours; the y-axis shows norethindrone concentration from 0 to 14000 pg/mL. Two curves depict concentration at Day 1 and Day 24, illustrating higher plasma levels at Day 24 compared to Day 1.*

FDA Label Image

6 (Image 06)

A line graph showing mean plasma Ethinyl Estradiol concentration over time following single- and multiple-dose oral administration of norethindrone acetate and ethinyl estradiol tablets to healthy female volunteers. The y-axis represents Ethinyl Estradiol concentration (pg/mL), and the x-axis represents time in hours up to 60 hours. Two lines are plotted: Day 1 (solid line) and Day 24 (dotted line), indicating concentration differences over time.*

FDA Label Image

7 (Image 07)

Table summarizing pharmacokinetic parameters for Norethindrone (NE) and Ethinyl Estradiol (EE) after single and multiple oral doses in healthy female volunteers. Parameters include maximum plasma concentration (Cmax), time to Cmax (tmax), area under the curve (AUC0-24), minimum plasma concentration at steady state (Cmin), elimination half-life (t½), and average plasma concentration (Cavg). Sex Hormone Binding Globulin (SHBG) values are also listed.*

FDA Label Image

8 (Image 08)

An illustration showing a vertical scale representing pregnancy rates per 100 women in one year, ranging from fewer than 1 to 85 or more pregnancies. The diagram correlates different birth control methods and their effectiveness, listing implants, injections, intrauterine devices, sterilization at the lowest pregnancy rates, and no birth control at the highest pregnancy rates. Intermediate methods like birth control pills, skin patch, vaginal ring, condoms, diaphragm, spermicide, withdrawal, and abstinence during fertile days are also included.*

FDA Label Image

9 (Image 09)

Illustration showing instructions for using the Larin 24 Fe birth control pill kit. It depicts a hand placing a day-label strip on the pill pack and directing users to start on Sunday or the first day of their period. The diagram indicates the sequence for taking active (pale yellow) and inactive (brown) pills from left to right each week.*

FDA Label Image

10 (Image 10)

FDA Label Image

11 (Image 11)

The image shows the packaging label for Larin 24 Fe, a kit containing Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate tablets. It includes 3 blister cards with 28 tablets each, delivering 1 mg/20 mcg dosage. The label features the product name, active ingredients, dosage strength, and manufacturer Northstar Rx LLC. It also provides usage instructions, warnings, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.